Company page
Abcellera Biologics Inc.
Abcellera Biologics Inc. is a public company traded under the ticker ABCL in the American market. The company has a market capitalization of approximately $1.97 billion. Abcellera focuses on advancing its proprietary technology for antibody discovery and development.
- Ticker
- ABCL:NASDAQ
- Asset type
- Stock
- Market cap
- $3.67B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD